Intrinsic value of T. Rowe Price Health Sciences Fund I Class (THISX)

Live fair value data for T. Rowe Price Health Sciences Fund I Class (THISX) is currently unavailable. Please check again shortly.

Fallback estimate (fair value API unavailable)

Intrinsic Value (Fair Value): Unlock fair value

Upside: +63.0%

Margin of Safety: +38.7%

Current Price: $290.00

Valuation: Undervalued

Confidence: 9.5/10

Visual Bar

Market Price $290.00Intrinsic Value Locked

Undervalued ✅Fair Value ⚖️Overvalued ❌

This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.

Is T. Rowe Price Health Sciences Fund I Class (THISX) undervalued or overvalued?

Based on the current model output, T. Rowe Price Health Sciences Fund I Class appears to be undervalued with a upside of 63.00%.

Fair value vs market price — T. Rowe Price Health Sciences Fund I Class (THISX)

Unlock premium access to view the live fair value comparison against current market price for THISX.

Unlock Fair Value

Frequently Asked Questions - THISX

How is THISX intrinsic value estimated?

We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for THISX.

Is THISX undervalued or overvalued right now?

THISX is currently shown as undervalued based on the difference between market price and intrinsic value.

How should I use the confidence score?

The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.

Related companies — intrinsic value

Peers for THISX: open their intrinsic value pages.

Explore Other Stocks

AAPL TSLA NVDA MSFT